
US-based Pressure BioSciences Inc. develops and commercializes novel pressure cycling technology for life sciences.
Pressure BioSciences Inc., based in Easton, United States, was founded with the mission to advance life sciences through innovative pressure-based technologies. The company specializes in the development and commercialization of Pressure Cycling Technology (PCT), which utilizes cycles of hydrostatic pressure to facilitate various biological and chemical processes. Their products and services cater to a wide range of applications, including sample preparation for genomics, proteomics, and small molecule studies, targeting researchers and institutions in the life sciences market.
Notable figures affiliated with Pressure BioSciences include key scientists and industry experts who have contributed to the development of PCT. The company has garnered attention from investors interested in cutting-edge biotechnology. Among its achievements, Pressure BioSciences has successfully launched several products under its PCT platform and expanded its market reach through strategic partnerships. The impact of their technology is evident in its adoption by leading research institutions, enhancing the efficiency and accuracy of scientific studies.
Companies similar to Pressure BioSciences include Fluidigm, Pacific Biosciences of California, BioLife Solutions and Protea Biosciences.
Pressure BioSciences was founded in 1978.
Pressure BioSciences' headquarters is located in South Easton, MA, US.
Pressure BioSciences' most recent funding round was for $5M (USD) in January 2016.
As of Jan 26, 2016, Pressure BioSciences has raised a total of $14.3M (USD).
Pressure BioSciences has 15 employees as of Feb 6, 2024.
BioLife Solutions